ZTZixin Tao

Zixin Tao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zixin Tao has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Beier Chen

    The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China

    1 shared publication
  • Bo Situ

    Department of Laboratory Medicine Nanfang Hospital, Southern Medical University Guangzhou Guangdong China

    1 shared publication
  • Chao Sheng

    Department of Obstetrics and Gynecology Nanfang Hospital, Southern Medical University Guangzhou Guangdong China

    1 shared publication
  • Dongni Wen

    Department of Obstetrics and Gynecology Nanfang Hospital, Southern Medical University Guangzhou Guangdong China

    1 shared publication
  • Fang He

    Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

    1 shared publication
  • Haoyue Hu

    Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

    1 shared publication

Latest Publications

  • Open Access

    Alterations in the Gut Microbiome and Metabolisms in Pregnancies with Fetal Growth Restriction

    by Zixin Tao, Yun Chen, Fang He, Jiawei Tang, Limei Zhan, Haoyue Hu, Ziling Ding, Shenghang Ruan, Yutao Chen, Beier Chen, et al.

    Downstream of the primary cause of fetal growth restriction are placental insufficiency and fetal malnutrition. Gut microbiota and metabolites appear to play an important role in the progression of gestation, while dysbiosis induces maternal and fetal complications.


  • Top Cited Papers
    Open Access

    Extracellular vesicles derived from Akkermansia muciniphila promote placentation and mitigate preeclampsia in a mouse model

    by Yun Chen, Zihao Ou, Menglan Pang, Zixin Tao, Xifen Zheng, Zhipeng Huang, Dongni Wen, Qianbei Li, Ruisi Zhou, Peng Chen, et al.

    Preeclampsia (PE) is a multisystem disorder with high maternal morbidity and mortality rates. Currently, no practical therapeutic approach is available to prevent PE progression, except for early delivery. Gut dysbiosis is associated with PE development. Previous data showed that the abundance of Akkermansia muciniphila (Am) was lower in patients with PE than in normotensive pregnant women. Here, in this study, decreased abundance of Am was observed in a PE mouse model. Also, we found that administration with Am could significantly attenuate systolic blood pressure, promote foetal growth and improve the placental pathology in mice with PE. Moreover, Am‐derived extracellular vesicles (AmEVs) were transferred from the gastrointestinal (GI) tract to the placenta and mitigated pre‐eclamptic symptoms in PE mice. These beneficial effects of AmEVs were mediated by enhanced trophoblast invasion of the spiral artery (SpA) and SpA remodelling through activation of the epidermal growth factor receptor (EGFR)–phosphatidylinositol‐3‐kinase (PI3K)–protein kinase B (AKT) signalling pathway. Collectively, our findings revealed the potential benefit of using AmEVs for PE treatment and highlighted important host–microbiota interactions.